BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18405179)

  • 21. Cutaneous lymphomas: what can we learn from location?
    Grange F; Antonicelli F
    Arch Dermatol; 2009 Jun; 145(6):710-2. PubMed ID: 19528430
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances in the treatment of primary cutaneous T-cell lymphoma.
    Rosen ST
    Clin Adv Hematol Oncol; 2007 May; 5(5):347-8. PubMed ID: 17673888
    [No Abstract]   [Full Text] [Related]  

  • 23. What's new in cutaneous T-cell lymphomas: 2006.
    Guitart J
    Semin Cutan Med Surg; 2006 Jun; 25(2):87-90. PubMed ID: 16908398
    [No Abstract]   [Full Text] [Related]  

  • 24. Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL).
    Dummer R
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S33-6. PubMed ID: 16516674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in the management of the cutaneous T cell lymphomas.
    Zic JA
    Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.
    Geskin LJ; Kwinta BD; Garcia-Saleem TJ; Akilov OE; Enz PA; Guenova E; Ortiz-Romero PL; Papadavid E; Quaglino P; Rozati S; Stonesifer CJ; Burns A; Stringer WS; Tarin E; Scarisbrick JJ
    J Am Acad Dermatol; 2023 Apr; 88(4):935-937. PubMed ID: 36375717
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous lymphomas and COVID-19: What is known so far?
    Elmasry MF; Youssef R; Elbendary A; Helmy K; Abdelkader HA
    Dermatol Ther; 2021 Jan; 34(1):e14463. PubMed ID: 33112053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing incidence trends of cutaneous B-cell lymphoma.
    Korgavkar K; Weinstock MA
    J Invest Dermatol; 2014 Mar; 134(3):840-842. PubMed ID: 24037340
    [No Abstract]   [Full Text] [Related]  

  • 29. Update on treatment of cutaneous T-cell lymphoma.
    Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ
    Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bibliography. Current world literature. Melanoma and other skin neoplasms.
    Curr Opin Oncol; 2004 Mar; 16(2):198-207. PubMed ID: 15083802
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous T-cell lymphoma.
    McFadden ME
    Semin Oncol Nurs; 1991 Feb; 7(1):36-44. PubMed ID: 2011657
    [No Abstract]   [Full Text] [Related]  

  • 32. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Photopheresis for cutaneous T-cell lymphomas].
    Laroche L
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S37-8. PubMed ID: 16385898
    [No Abstract]   [Full Text] [Related]  

  • 34. Emerging insights on the biology and treatment of cutaneous T-cell lymphoma.
    Porcu P; Sahu J; Shi W
    Chin Clin Oncol; 2019 Feb; 8(1):1. PubMed ID: 30818956
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy algorithm for cutaneous T-cell lymphomas].
    Bachelez H; Bagot M; Beylot-Barry M; Claudy A; Grange F; Grob JJ; Dereure O; Dréno B; D'Incan M; Laroche L; Viraben R;
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S43-4. PubMed ID: 16385900
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous T cell lymphomas.
    Smith N; Spittle M
    BMJ; 1994 May; 308(6939):1303. PubMed ID: 8205037
    [No Abstract]   [Full Text] [Related]  

  • 37. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Local treatments of cutaneous T-cell lymphomas].
    Bachelez H
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S23-6. PubMed ID: 16385895
    [No Abstract]   [Full Text] [Related]  

  • 39. Time to treatment failure as an end point for cutaneous T-cell lymphoma.
    Zackheim HS
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):283-4. PubMed ID: 9486695
    [No Abstract]   [Full Text] [Related]  

  • 40. Incidence of cutaneous T-cell lymphoma in the Republic of Ireland between 1994 and 2019.
    McFeely O; Walsh PM; Desmond R; Enright H; Costa Blasco M; Wolinska A; Murphy L; Andrawis M; Beatty P; Doyle C; Tobin AM; O'Gorman S; Molloy K
    J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):e145-e147. PubMed ID: 37705380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.